US$ 20.05
is rybelsus a glp-1 GLP-1? Understanding This Oral Diabetes Medication Novo's Rybelsus gains FDA expansion
Description
Status: Recruiting Double-blinded randomized clinical trial investigating the effects of subcutaneous semaglutide vs placebo on alcohol consumption in 108 patients diagnosed with alcohol use disorder and comorbid obesity over a 26-week period

Multiple mechanisms likely contribute: Weight loss: Reduces cardiac workload, improves blood pressure, and improves lipid profiles

Real world analysis by Prime Therapeutics

Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, et al

Diamant M, Van Gaal L, Stranks S, Northrup J, Cao D, Taylor K, et al

BMJ Open 2013;3:e001986.ArticlePubMedPMC 33
